Manager TitleAgeSince
Chief Executive Officer - 26/11/2013
Director of Finance/CFO 68 13/10/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 26/11/2013
Director/Board Member 66 24/10/2018
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+8.75%+71.89% - - 12.69M
+0.33%+1.37%+64.03%+119.11% 55.63B
+0.82%+15.05%+79.93%+84.34% 52.25B
+1.36%+0.36%-14.06%-14.69% 23.07B
-1.04%+7.91%+1.61%+419.24% 22.41B
-0.18%+7.20%+32.16%-14.07% 17.32B
-1.10%+4.00%+28.70%-34.51% 15.94B
-3.35%+8.96%+132.20%+290.18% 13.47B
+2.89%+5.51%+27.11%+181.45% 13.77B
+1.31%+0.53%+28.62% - 12.43B
Average +0.98%+4.78%+42.26%+128.88% 25.14B
Weighted average by Cap. +0.26%+5.13%+48.50%+120.17%
Logo Acticor Biotech
Acticor Biotech is specialized in the research and development of medicines for the treatment of thrombotic diseases, in particular acute ischemic strokes and pulmonary embolisms. The group has one product in Phase II/III clinical development (Glenzocimab).
Employees
31